Filing Details
- Accession Number:
- 0001209191-16-139902
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2016-09-02 20:36:30
- Reporting Period:
- 2016-06-30
- Filing Date:
- 2016-09-02
- Accepted Time:
- 2016-09-02 20:36:30
- Original Submission Date:
- 2016-07-01
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1594864 | Juno Therapeutics Inc. | JUNO | () | 4/A |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1480212 | Edgar Hans Bishop | C/O 307 Westlake Avenue N Ste 300 Seattle WA 98109 | Ceo & President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-06-30 | 44,000 | $6.36 | 2,657,859 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-06-30 | 108,894 | $38.41 | 2,548,965 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2016-06-30 | 6,356 | $39.18 | 2,542,609 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2016-06-30 | 44,000 | $0.00 | 44,000 | $6.36 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 795,506 | 2024-09-08 | No | 4 | M | Direct |
Footnotes
- This Form 4/A is being filed solely to correct the transaction code used for the sales that were reported in the Form 4 filed by the reporting person on July 1, 2016. The transaction code was erroneously reported as "D" instead of as "S."
- The sales reported on this Form 4/A were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 17, 2016.
- This transaction was executed in multiple trades at prices ranging from $38.03 to $39.02. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- This transaction was executed in multiple trades at prices ranging from $39.03 to $39.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- 1/48th of the shares subject to the option became vested and exercisable on October 9, 2014 and 1/48th of the shares subject to the option vested monthly thereafter.
Billionaire Hedge Funds
